2015 annual financial data
Marker Therapeutics 2015 Operating margin
Marker Therapeutics 2015 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -6,158,958 USD and net income was -34,066,390 USD.
Operating cash flow was -4,343,397 USD.
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -6,158,958 USD
- Net income
- -34,066,390 USD
- Operating cash flow
- -4,343,397 USD